Medgenics, Inc. to Present at the Piper Jaffray 23rd Annual Healthcare Conference

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that the Company will be participating in the Piper Jaffray 23rd Annual Healthcare Conference being held November 29-30, 2011 at the Palace Hotel in New York City.